A Novel Analgesia Technique for ACL Reconstruction

NCT03292926 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

A comparison of two anesthetic techniques-- the Adductor Canal Block (ACB) and the Adductor Canal Block with Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (ACB/IPACK)-- in patients undergoing bone-tendon-bone (BTB) anterior cruciate ligament (ACL) reconstruction.

Conditions

  • Anterior Cruciate Ligament Injury

Interventions

DRUG

Bupivacaine

Bupivacaine will help treat pain and sensation after ACL repair

DEVICE

Ultrasound

Ultrasound will guide anesthesiologist in performing the different nerve blocks

DRUG

Dexamethasone

Dexamethasone will be used to prolong block duration

Sponsors & Collaborators

  • Hospital for Special Surgery, New York

    lead OTHER

Principal Investigators

  • Jonathan Beathe, MD · Hospital for Special Surgery, New York

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-04
Primary Completion
2020-03-06
Completion
2020-04-16
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03292926 on ClinicalTrials.gov